Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,886.24
(
1.02%
)
US TECH 100
24,753.20
(
1.27%
)
Dow Jones
48,218.25
(
0.63%
)
Brent Oil
95.65
(
0.19%
)
Bitcoin
74,456.00
(
-0.06%
)
News Focus
News Focus
Post# of 9090
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122865
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: marthambles post# 3133

Thursday, 01/05/2023 10:04:24 AM

Thursday, January 05, 2023 10:04:24 AM

Post# of 9090
I still expect RVNC to announce the FDA's acceptance of the sBLA (and the PDUFA date) in an all-in-one PR that also sets forth the company's clinical and financial guidance for 2023.

If there were any issues, would disclosure be required?

The only "issue" at this stage of the sBLA would be an RTF letter, which would definitely require disclosure by RVNC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote